Brent Crude
SMI in Red, 8 of 20 Blue Chips Gain; Nestlé Loses After Russia Report; Gold Rises
Swiss stock market closes lower after a positive week; gold prices increase amid rising interest rates; Nestlé shares fall after Russia business report.
Frankfurt Stocks Tumble as Brent Crude Breaks $100
The DAX fell 1.66% to 25,576.45 as Brent crude surpassed $100 a barrel, weighing on European equities ahead of the ECB's expected rate hike.
Swiss Market Index holds gains amid Fed hike, UBS gains amid Ständerat vote
The SMI advances modestly as the Swiss market reacts to the Fed’s 25 bps rate hike and UBS’ capital rules vote, while Roche and Rieter face profit-taking pressures.
Swiss Market Index rises as UBS gains amid Fed rate hike, Helvetia Baloise outperforms
UBS gains after Ständerat approves stricter capital rules; Roche and Rieter face downgrades; oil prices ease amid Saudi export diversification efforts.
Swiss Market Index rises; Roche downgraded, Rieter hit by UBS rating cut
Swiss equities mixed as SMI gains, but Roche and Rieter face downgrades; oil prices dip amid geopolitical uncertainty and Fed rate hike expectations.
SMI set for higher open; oil eases; Fed lifts rates again
Swiss markets brace for a firmer start as oil retreats from four-month highs, the Fed delivers its first hike in over three years, and AI-focused semiconductor names remain in demand despite broader US equity weakness.
DAX Falls 1.7% on Oil Above $100, Eyes ECB Rate Decision
The DAX dropped to its lowest level since late July as Brent crude breached $100, while investors awaited Thursday's expected ECB rate hike.
SMI Falls Below 14,000 as Oil Hits $100; Meta and Chime Lead Gainers
Switzerland's SMI slipped below 14,000 for the first time since mid-June on rising oil and inflation fears. Meta rose around 5% ahead of its AI agent launch, while Chime jumped 11% on a $590 million bank acquisition.
Swiss SMI falls below 14,000 as Brent oil hits $100
Switzerland's benchmark index slipped to its lowest level since mid-June amid oil-driven inflation worries, while luxury, construction and pharma stocks diverged.
FTSE 100 drops 1.3% as Gulf strikes push Brent above $100
European shares retreated as oil surged above $100 following Iranian attacks on shipping and US forces, with markets pricing in a persistent risk premium.
Swiss stocks fall as oil pressure hits UBS, Richemont; Adecco, Barry Callebaut rise
Swiss shares slipped midweek on oil prices and US weakness, with Novartis, UBS and Richemont under pressure while Adecco, DocMorris and Barry Callebaut moved sharply.
Swiss SMI set lower; 19 of 20 SMI stocks down, DocMorris and Barry Callebaut in focus
Swiss equities are seen lower before the open, with 19 of 20 SMI shares down; DocMorris falls on a new convertible bond while Barry Callebaut steadies on a calmer cocoa outlook.
US Futures Slip; SMI Tumbles 1.3% on Oil, Rates, Bank Woes
The SMI fell 1.3%, with UBS leading declines as Powell's 5.041% yield and Brent crude near $108 weigh on stocks.
SMI widens losses; UBS, Partners Group fall; Centiel gains
The Swiss benchmark fell 1.3% as UBS dropped 4%, Brent topped $107 and traders awaited the Fed decision; Centiel rose 7% on a plant acquisition.
FTSE 100 falls as oil rises and AI safety dispute clouds markets
European and U.S. shares eased as Brent crude climbed on a Saudi pipeline outage, while AI leaders clashed over development speed and UK labour data showed cooling pay growth.
Swiss stocks fall after open; UBS, Partners Group and SMG drop
SMI opens 0.55% lower as UBS and Partners Group fall, SMG drops after ownership changes, Centiel rises, and oil gains ahead of the Fed decision.
US stocks set for mixed open as oil nears $100 and rate-hike odds rise
Dow seen 0.8% lower at 53,013 and Nasdaq 100 0.1% higher at 29,568, while Brent tops $98 and ECB and US rate-hike expectations weigh on sentiment.
DAX Flat as Oil Hits $100; Fresenius, Kion Lead Gains
The DAX stalled near 26,007 as Brent approached $100 a barrel on Middle East supply fears. Fresenius and Kion led gains while Infineon fell 4% on a Morgan Stanley downgrade.
US stocks fall as oil nears $100; Novartis posts steep loss
US indices slipped on higher oil prices and rate-hike concerns, while Novartis fell 9.8% after another trial disappointment and the SMI stayed near its low.
Novartis plunges as oil and rate worries push US and Swiss stocks lower
Novartis fell more than 9% after a phase-III miss, dragging the SMI lower as US stocks slipped on rising oil prices and rate-hike expectations.
US Markets Slide as Oil Hits $98; Novartis Plunges Toward Record Loss
Brent crude climbs toward $100 on Middle East tensions, weighing on Wall Street and Switzerland's SMI. Novartis falls nearly 10% after Phase III trial miss, wiping out roughly CHF 24 billion in market value.
Dax slips as Brent crude nears $100 and oil prices pressure German stocks
The Dax fell to 25,975 in early afternoon trade as Brent crude approached $100 and WTI and European gas prices rose, while stock-specific ratings drove moves in Dax and MDax names.
US Stocks Expected to Open Mixed After Holiday; Oil Prices Pressuring Sentiment; SMI Continues Decline; Novartis Targets Record Daily Loss
US stock indices show slight movements before market open; oil prices rise, fueling concerns over rising interest rates; Swiss Market Index (SMI) continues to fall; Novartis shares plunge, potentially setting a record daily loss.
Novartis trial miss drags Swiss SMI lower; Nestlé, Ascom gain
Novartis shares fell nearly 10% after Del-desiran missed a Phase III endpoint, pulling the SMI lower while Nestlé, Sandoz and Ascom gained and Brent approached $100.